A detailed history of West Paces Advisors Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, West Paces Advisors Inc. holds 85 shares of CRSP stock, worth $4,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Previous 85 -0.0%
Holding current value
$4,663
Previous $4.59 Million 13.03%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Dec 18, 2023

BUY
$39.19 - $65.67 $3,331 - $5,581
85 New
85 $3.46 Million
Q1 2022

Dec 18, 2023

SELL
$53.19 - $79.24 $2,659 - $3,961
-50 Reduced 58.82%
35 $2.2 Million
Q4 2021

Dec 19, 2023

SELL
$70.09 - $111.29 $3,504 - $5,564
-50 Reduced 58.82%
35 $2.65 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.28B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.